Transformation of myelodysplastic syndrome to mixed phenotype acute leukaemia
Main Authors: | Louis Do, John Giannoutsos |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-07-01
|
Series: | eJHaem |
Online Access: | https://doi.org/10.1002/jha2.59 |
Similar Items
-
Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia
by: R Edlin, et al.
Published: (2010-05-01) -
Our treatment experience with azacytidine in patients with acute myeloid leukaemia, chronic myelomonocytic leukaemia and myelodysplastic syndrome
by: Peter Černelč, et al.
Published: (2012-12-01) -
Low expression of the putative tumour suppressor gene gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia.
by: Boultwood, J, et al.
Published: (2004) -
Serial monitoring of circulating tumour DNA on clinical outcome in myelodysplastic syndromes and acute myeloid leukaemia
by: Xinping Zhou, et al.
Published: (2023-07-01) -
Frequent Mutation of the Polycomb-Associated Gene ASXL1 in the Myelodysplastic Syndromes and in Acute Myeloid Leukaemia
by: Boultwood, J, et al.
Published: (2009)